ent-7alpha,12beta-Dihydroxy-16-kauren-19,6beta-olide

Metabolite details

Identifier

OSYJLXUUZYSFTC-UHFFFAOYSA-N

InChI Key

OSYJLXUUZYSFTC-UHFFFAOYSA-N

IUPAC name

4,9-dihydroxy-1,13-dimethyl-6-methylidene-11-oxapentacyclo[8.6.1.15,8.02,8.013,17]octadecan-12-one

Preferred name

ent-7alpha,12beta-Dihydroxy-16-kauren-19,6beta-olide

INN name

—

Synonym

—

ChEBI

CHEBI:192879

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Transcriptome and Metabolome Analyses Reveal Differences in Terpenoid and Flavonoid Biosynthesis in Cryptomeria fortunei Needles Across Different Seasons

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Summer_vs_Winter